NEW YORK (GenomeWeb News) — The Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland has bought Partek’s tiling and exon array data-handling software, Partek said yesterday.
Partek said FMI’s Functional Genomics Lab will use its genomics suite software to analyze data from studies of epigenetics, growth control, and neurobiology.
Partek, based in St. Louis, Mo., is a genomics software developer specializing in an Affymetrix GeneChip-compatible platform used to identify and quantify data patterns.
Partek said its genomics suite handles data from “genomic and proteomic studies, high throughput-screening campaigns, and computer-aided drug design.”
Financial terms of the deal were not released.